ChiCTR2000033155 版本V1.3 版本创建时间2020/05/23 12:10:05 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000033155 

最近更新日期:

Date of Last Refreshed on:

2020-05-23 12:07:08 

注册时间:

Date of Registration:

2020-05-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于蛋白组学的慢性心力衰竭心气阴两虚证生物标记物研究

Public title:

Study on biomarkers of Qi and Yin deficiency syndrome in chronic heart failure based on proteomics

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于蛋白组学的慢性心力衰竭心气阴两虚证生物标记物研究

Scientific title:

Study on biomarkers of Qi and Yin deficiency syndrome in chronic heart failure based on proteomics

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

姜泱 

研究负责人:

胡志希 

Applicant:

Yang Jiang 

Study leader:

Zhixi Hu 

申请注册联系人电话:

Applicant telephone:

+86 18890366815

研究负责人电话:

Study leader's telephone:

+86 13574812411

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

z33261@163.com

研究负责人电子邮件:

Study leader's E-mail:

zhixihu@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖南省长沙市岳麓区麓山路58号

研究负责人通讯地址:

湖南省长沙市岳麓区含浦科教园学士路300号

Applicant address:

58 Lushan Road, Yuelu District, Changsha, Hu'nan, China

Study leader's address:

300 Xueshi Road, Hanpu science and education Park, Yuelu District, changsha, Hu'nan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

湖南省中医药研究院附属医院

Applicant's institution:

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital

研究负责人所在单位:

湖南省中医药研究院附属医院

Affiliation of the Leader:

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(202005)17

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

湖南省中医药研究院附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of Affiliated Hospital of Hu'nan Academy of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

戎宽

Contact Name of the ethic committee:

Kuan Rong

伦理委员会联系地址:

湖南省长沙市岳麓区麓山路58号

Contact Address of the ethic committee:

58 Lushan Road, Yuelu District, Changsha, Hu'nan, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

湖南省中医药研究院附属医院

Primary sponsor:

Hu'nan Academy Of Traditional Chinese Medicine Affiliated Hospital

研究实施负责(组长)单位地址:

湖南省长沙市岳麓区麓山路58号

Primary sponsor's address:

58 Lushan Road, Yuelu District, Changsha, Hu'nan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南

市(区县):

长沙

Country:

China

Province:

Hu'nan

City:

Changsha

单位(医院):

湖南省中医药研究院附属医院

具体地址:

岳麓区麓山路58号

Institution
hospital:

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital

Address:

58 Lushan Road, Yuelu District

经费或物资来源:

科研经费

Source(s) of funding:

Grants for Scientific Research

Target disease:

Chronic heart failure

Target disease code:

研究类型:

基础科学研究

Study type:

Basic Science

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

① 获取慢性心力衰竭心气阴两虚证的特征蛋白质及代谢物; ② 构建诊断慢性心力衰竭心气阴两虚证的诊断模型并进行ROC曲线验证。  

Objectives of Study:

1. To obtain the characteristic proteins and metabolites of qi Yin deficiency syndrome in chronic heart failure; 2. To construct a diagnosis model for chronic heart failure with qi and Yin deficiency syndrome and verify the ROC curve.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

a.符合慢性心力衰竭西医诊断标准;
b.符合慢性心力衰竭心气阴两虚证中医诊断标准;
c.签署知情同意书者;
d.年龄<85岁的慢性心力衰竭患者;
e.心力衰竭的基础病因为心血管疾患,如高血压、冠心病、心肌病等引起者。

Inclusion criteria

1. Patients who meet the western medicine diagnosis standard of chronic heart failure;
2. Patients who meet the TCM diagnostic standard of Heart Qi Yin deficiency syndrome of chronic heart failure;
3. Patients willing to sign informed consent;
4. Patients with chronic heart failure younger than 85 years old;
5. The basic disease of heart failure is caused by cardiovascular diseases such as hypertension, coronary heart disease, cardiomyopathy, etc..

排除标准:

a. 拒绝接受此项研究或近1月参加其他研究的患者;
b. 合并有严重肝、肾、造血系统疾病、恶性肿瘤的患者;依从性差。
c. 合并急性冠脉综合征、肺栓塞和急性脑血管病的患者;
d. 脏器移植患者;
e. 恶性肿瘤终末阶段恶病质状态患者。

Exclusion criteria:

1. Patients who refuse to accept this study or participate in other studies in the past 1 month;
2. Patients with severe liver, kidney, hematopoietic system diseases and malignant tumors have poor compliance;
3. Patients with acute coronary syndrome, pulmonary embolism and acute cerebrovascular disease;
4. Organ transplant patients;
5. Patients with terminal stage cachexia.

研究实施时间:

Study execute time:

From 2020-06-01 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-01 00:00:00 To 2020-12-31 00:00:00  

干预措施:

Interventions:

组别:

慢性心力衰竭心气阴两虚证组

样本量:

10

Group:

Qi and Yin deficiency syndrome group

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

慢性心力衰竭非心气阴两虚证

样本量:

10

Group:

non Qi and Yin deficiency syndrome group

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

健康对照组

样本量:

10

Group:

Healthy control group

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖南 

市(区县):

长沙 

Country:

China 

Province:

Hu'nan 

City:

Changsha 

单位(医院):

湖南省中医药研究院附属医院 

单位级别:

三级甲等 

Institution
hospital:

Hu'nan Academy of Traditional Chinese Medicine Affiliated Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

蛋白组学

指标类型:

主要指标

Outcome:

Proteomics

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据上传至发表学术刊物指定数据库

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Upload the original data to database of the scientific publication

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据收集采用CRF方式,保存于湖南省中医药研究院附属医院。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data are collected by CRF and stored in the affiliated hospital of hunan academy of traditional Chinese medicine.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-05-22 13:02:31